Logo

Syncom Formulations Share Price

Syncom Formulations (INR)18.180.9   (5.4%)

Exchange ScripsBSE524470NSESYNCOMFISININE312C01025

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Syncom Formulations Performance

Market performance
Open price17.25
High18.5
Volumes2971905
Prev Close18.18
Low17.2
Closing date2025-01-14
Historical performance
1 Year High27.90
3 Year High27.90
5 Year High27.90
1 Year Low10.95
3 Year Low4.60
5 Year Low4.60

Syncom Formulations Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
1719
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
67.51
Dividend Yield
Dividend Yield
N/A

Syncom Formulations Investment Returns

1 Year
11.2%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Syncom Formulations Technicals

IndicatorsValueSignal
5-DMA18.34Bearish
10-DMA19.29Bearish
20-DMA19.83Bearish
50-DMA20.55Bearish
100-DMA21.02Bearish
200-DMA17.32Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1313131313
Foreign Investors---------------
Domestic Investors1313131313
Public Investors469229376517325748289969224239
Government---------------

Syncom Formulations Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2017
Other Income13514612028
Operating Profit434345320193
Interest4734193
Depreciation47453931
Profit Before Tax340266262159
Consolidated Net Profit253201198105
Adjusted EPS------------

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2017
Share Capital940940862781
Total Reserves194116201309393
Minority Interest------------
Total Non-Current Liabilities100877877
Total Liabilities4047377830821839
Capital Work in Progress---256622
Total Assets4047377830821839

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2017
Cash Flow from Operating Activities-60105163138
Cash Flow from Investing Activities830-450-271-177
Cash Flow from Financing Activitie-1463508347
Net Cash Inflow / Outflow6256-248
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 67.51.
  • 3Y Stock Price CAGR of the stock is 49.8.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹434 Million.
  • The company generated revenue of ₹2634 Million in the previous financial year.

Syncom Formulations

18.180.9   (5.4%)

Investment Amount: ₹ 1590
Current Value: ₹ 1818
Performance: 14.3%
P/L: ₹ 228
Top Gainers
SymbolChange%
BRNL47.17(20%)
SURYAROSNI280.05(20%)
ADANIPOWER537(19%)
KHANDSE29.12(19%)
IOB53.77(18%)
Top Losers
SymbolChange%
SABTNL845.05(-10%)
HCLTECH1813.55(-9%)
DNAMEDIA5.8(-8%)
KFINTECH1172.2(-7%)
PRSMJOHNSN152.92(-6%)
UNITDSPR1407.25(-5%)
TVVISION12.77(-5%)
YAARI13.88(-5%)
Similar stocks

Zota Health Care

44.3

989.5

December 14 - January 14

Bajaj Healthcare

29

545

December 14 - January 14

Medico Remedies

23.6

61.98

December 14 - January 14

Brooks Laboratories

15.9

174.84

December 14 - January 14

Blue Jet Healthcare

15.8

581.4

December 14 - January 14

Concord Biotech

10.2

2327.4

December 14 - January 14

Biocon

9.9

387.65

December 14 - January 14

Gufic Biosciences

8.8

469.5

December 14 - January 14

Announcing Stock of the Month!

Stock of the Month
Stock of the Month